Diabetes Drug Market Size

1. Global Diabetes Drugs Market

2. Report Description and Highlights Analyst View: Global Diabetes Drugs Market is projected to go beyond US$ 76 Billion by the end of the year 2024. Diabetes is a health disorder in which the level of blood glucose gets elevated in the human body. In general; Diabetes is a chronic disease caused when pancreas cannot effectively use the insulin it produces to regulate the level of blood sugar in the human body. Type 1 Diabetes: Type 1 diabetes also known by the name of juvenile or childhood-onset or insulin-dependent diabetes is characterized by the deficient insulin production and needs insulin administration daily. The cause of type 1 diabetes is still unknown and is not curable with existing knowledge. Type 2 Diabetes: Type 2 diabetes formerly known as adult-onset or non-insulin dependent diabetes results from the human body’s ineffective use of insulin. Around the world, the majority of the population suffering from diabetes comprises of type 2 diabetes and is mainly caused due to body overweight and physical inactivity. Until lately, type 2 of diabetes was seen only among the adults but now it is also occurring significantly among the children.

3. Various Types of Diabetes Drugs in the Market Diabetes is a serious disease; and there is no treatment available that can cure diabetes. All over the world, diabetes prevalence is growing rapidly specially in the middle and low-income countries. Moreover, diabetes is also among the primary reason of kidney failure, heart attacks, strokes, lower limb amputation, and blindness. Considering the seriousness of the disease, it has dragged the interest of various biopharmaceutical companies for developing effective new lifesaving and life-changing drugs for the treatment. Currently, a number of various types of diabetes drugs are available in the market and more than 170 diabetes drugs are in their developmental stage which again provides a seamless opportunity to the Diabetes Drugs Market. Read more here: https://www.renub.com/diabetes-drug-market-p.php

4. Forecast for Diabetes Drugs Market Share by Insulin (%) Forecast for Diabetes Drugs Market Share by Insulin (%), 2018 - 2024 Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report

5. 420 Million adults suffering from diabetes in 2016 Some of the Diabetes Drugs Available in the Market Include: DPP-4 Inhibitors – These drugs inhibit the enzyme DPP-4 which increases the level of GLP-1 named hormone that stimulates the insulin production in the human body and decreases the production of glucagon hormone when the level of blood glucose is high. Insulin Drugs – Pancreas produced the hormone called insulin which stimulates cells to remove glucose from the blood in the human body. Usually, insulin is released when the human body has a high level of sugar in the blood to bring levels back into a normal range. Over the last few decades, the world has witnessed a considerable increase in the diabetes population. According to the International Diabetes Federation (IDF), there were nearly 420 Million adults suffering from diabetes in 2016 and is expected to reach 625 Million by the year 2040. Want more Information about this market? Request a free sample copy: https://www.renub.com/contactus.php

6. Global Forecast for Diabetes Drugs Market by Therapy (%) Forecast for Diabetes Drugs Market by Therapy (%) 2018 – 2024 Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report

7. Key Topics Covered in Diabetes Drugs Market 1. Introduction 1.1 Market Definition 1.2 Currency Conversion 2. Research Methodology 3. Executive Summary 4. Global Diabetes Drug Market 5. Market Share – Global Diabetes Drug 5.1 Disease Type 5.2 Therapy – (Oral, Injection, Insulin) 5.3 Oral Drug 5.4 Injection Drug 5.5 Insulin 5.6 Regions – Type 1 Diabetes Drug 5.7 Regions – Type 2 Diabetes Drug 6. Disease Type – Global Diabetes Drug Market 6.1 Type 1 Diabetes 6.2 Type 2 Diabetes Therapy – Global Diabetes Drug Market 7.1 Oral Drugs Market 7.2 Injectable Drugs Market 7.3 Insulin Market

8. Key Topics Covered in Diabetes Drugs Market Region – Type 1 Diabetes Drug Market 8.1 United States 8.2 European Union 8.3 Japan 8.4 Canada Region – Type 2 Diabetes Drug Market 9.1 United States 9.2 European Union 9.3 Japan 9.4 China 9.5 India 9.6 Brazil 10. Regions – Diabetic Population 10.1 United States 10.2 European Union 10.3 Japan 10.4 Canada 10.5 China 10.6 India 10.7 Brazil 11. Key Players Analysis 11.1 Novo Nordisk Overview 11.2 Merck & Co Overview 11.3 Eli Lilly Overview 11.4 AstraZeneca Overview 11.5 Johnson & Johnson Overview 11.6 BoehringerIngelheim Overview 12. Mergers & Acquisitions

9. Global Diabetes Drugs Market • Market Dynamics • 13.1 Growth Drivers 13.2 Challenges • 13.3 Opportunities • Browse Related Report : • Epilepsy Drugs Market • Allergic Conjunctivitis Market • Contact Us • Tel: +1-678-302-0700 (US), +91-120-421-9822 (INDIA) • Email: info@renub.com